Fig. 4From: Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapiesCe NPs-based self-therapeutic nanomaterials for the topical treatment of psoriasis. β-cyclodextrin modified ceria nanoparticles were designed as a ROS scavenger nanozyme to transdermal delivery of dithranol for the combinational therapy of psoriasis. Reproduced with permission [178]. Copyright 2020, Dove Medical PressBack to article page